Bionet Corp. (1784)

Overview

BIONET Corp. is a recognized entity in the realm of biotechnology, specifically focused on the domain of cord blood banking. Established in 1999 and rooted in Taipei City, Taiwan, BIONET Corp. extends its pivotal services both domestically and on an international scale. The core of its operations revolves around the preservation of stem cells derived from different sources, aiming to harness these cells’ potential in future therapeutic applications. Further, it stands out for offering a suite of genetic testing services, positioning itself as a comprehensive provider in the biotechnological and healthcare industry.

Products and Services

• Stem Cell Banking

  An array of services centered on the storage of valuable stem cells, including but not limited to cord blood, mesenchymal stem cells, dental pulp stem cells, and adipose-derived stem cells. BIONET Corp. offers a secure and innovative approach to preserve these cells, which might be pivotal for future medical treatments and regenerative medicine.

• PBSC + Immune Cells

  This service is dedicated to the storage of Peripheral Blood Stem Cells (PBSC) along with various immune cells, underscoring the company’s commitment to advancing medical treatments that could leverage the body's own defense mechanisms for therapeutic purposes.

• Genetic Testing Services

  BIONET Corp. not only focuses on cell storage but also extends its expertise to genetic testing, providing valuable insights into genetic predispositions and enabling preemptive steps in healthcare management.

• Stem Anti-Aging Products

  Delving into the cosmetic and wellness arena, the company offers products targeted towards anti-aging. These are based on stem cell research, aiming to provide rejuvenating effects by tapping into the regenerative properties of stem cells.

• ANIKINE Series Products

  A unique line of products developed by BIONET Corp. that likely encompasses a range of applications possibly geared towards therapeutic and regenerative medicine, although specifics are not detailed, the name suggests innovation in biotechnological applications.

• Exosome Therapy

  Marking a novel approach in cell-free therapy, Exosome therapy represents the company’s venture into cutting-edge biotechnological treatments. Exosomes are small vesicles released by cells that can mediate communication between cells and may be harnessed for therapeutic purposes, signifying BIONET Corp.'s forward-thinking in medical science.